Why Co-Diagnostics Stock Is Crashing Today

Shares of the molecular diagnostic company Co-Diagnostics (NASDAQ: CODX) are getting hammered this morning. The stock is down by 18.3%, as of 10 a.m. EST Tuesday morning. 

What's spooking investors today? Ahead of the opening bell, Maxim Group analyst Jason McCarthy downgraded Co-Diagnostics' stock over valuation concerns. 

Image source: Getty Images.

Continue reading

Source Fool.com